Global Urinary Tract Cancer (Types, Diagnostic Techniques, Treatment Procedures and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2014 - 2021Market

  • ALL178778
  • April 2018
  • Pharmaceuticals

One of the early symptoms of urinary tract cancer is the presence of blood in the urine, haematuria. As cited in WHO report urinary tract cancer was the ninth-most highly occurent cancer types in 2012 and have high reoccurrence rate as well. The risk of acquiring bladder cancer is high among smokers, aging population, workers at chemical industry, and among people with urinary tract infections. Timely diagnosis of Urinary tract cancers help design efficient treatment approaches aimed at eliminating the disease. As per few research studies it has been identified that around 75% to 80% of the cancer patients survive if it is diagnosed in the early stages. The major factors favoring the growth of the urinary tract cancer treatment market are increasing incidence of urinary tract cancer worldwide owing to rising sedentary lifestyle, geriatric population, rising smoking population and rigorous research activities towards developing urinary tract cancer therapeutics. Clinical trial review of the therapeutics to treat urinary tract cancer seems to provide a lucrative growth prospects for this market. 

The global urinary tract cancer market is segmented on the basis of types, diagnostic techniques, treatment procedures and geography. On the basis of types urinary tract cancer market is further categorized into Urothelial carcinoma, Squamous cell carcinoma, Adenocarcinoma and others. Among the urinary tract cancer types, urothelial carcinoma is the most-prevalent with ~90% to 95% occurrence rate, globally. Based on diagnostic techniques it is segmented into Cystoscopy, Urine analyses, Transurethral resection of tumor and Imaging tests. Being a part of initial evaluation in diagnosis of any urinary tract cancer, cytoscopy is the most important investigation for bladder cancer. Segmentation on the basis of treatment procedures categorizes the market into Surgery, Intravesical therapy, Chemotherapy, and Radiation therapy. Geographically, the global urinary tract cancer market is segmented into North America, Europe, Asia-Pacific and LAMEA. Factors such as higher occurrence rate of urinary tract cancer, higher healthcare spending, availability of advanced healthcare services & technology, reimbursement coverage and relatively higher rate of awareness are driving the growth of the urinary tract cancer market in North America and Europe.

Some key market players are Spectrum pharmaceuticals Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Genzyme Corporation, F. Hoffmann-La Roche Ltd., Shionogi & Co., Ltd., Kyowa Hakko Kirin Co., Ltd., Medical Enzymes AG, IkerChem S.L., and Amgen Inc. 


  • This study provides an insightful analysis of the global urinary tract cancer market with current and future trends to identify lucrative investment pockets in the market
  • This report also provides information regarding key drivers, restraints and opportunities with impact analysis
  • Porter’s Five Forces analysis examines the competitive structure of the global urinary tract cancer market and would assist market strategists in making decisions. 
  • Pin-point analysis of geographic segments helps to identify opportunities for growth within the global urinary tract cancer market
  • Identification of key investment pockets for urinary tract cancer market are providing strategic assistance to decision makers
  • Market attractiveness analysis has been included for various product segments, testing procedures, end users and geographic regions with detailed analysis of factors responsible for rapid growth of the market segments

The global urinary tract cancer market is segmented into four categories: types, diagnostic techniques, treatment and geography. 


  • Urothelial Carcinoma
  • Squamous Cell Carcinoma
  • Adenocarcinoma
  • Others (small cell cancer, pheochromocytoma, and sarcoma)


  • Cytoscopy
  • Urine analyses
  • Biopsy
  • Imaging test 
    • Computed Tomography (CT) Scan
    • Magnetic Resonance Imaging (MRI) scan
    • Bone Scan
    • X-ray Scan
    • Ultrasound


  • Surgery
  • Intravesical therapy
  • Chemotherapy
  • Radiation therapy


  • North America
  • Europe
  • Asia-Pacific
Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+91 20 66346066
--- or ---



Global General Medicine Education Publishing Market (Type, Geography) Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation, Forecast (2013-2020)

General medicine is a branch of medicine that deals with diagnosis and treatment of diseases associated with internal organs. It is also called as Internal Medicine. General medicine education market has shown substantial growth due to the adoption of internal medicine as a career option by medical students.

April 2018| $5370 | Pre Book Price:$4699

Cancer Vaccine Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Cancer vaccines are biological response modifiers. These vaccines work by stimulating or restoring the immune system�s ability to fight against infections and diseases. It is used either as stand-alone therapies ...

April 2018| $4995 | Pre Book Price:$4371

World Active Pharmaceutical Ingredient (API) Market - Opportunities and Forecasts, 2014 - 2020

Increase in Abbreviated New Drug Applications (ANDA) over the past years has fostered the demand for API market. Furthermore, Indian companies making increased entries related to Drug Master File (DMF) ...

April 2018| $5370 | Pre Book Price:$4699

Anterior Uveitis Asia-Pacific Market Research Report, 2014 - 2020

Anterior uveitis is an eye inflammation that involves middle layer of the eye specifically, iris (colored part of the eye) and ciliary body (adjacent tissue). Untreated anterior uveitis results in ...

April 2018| $2850 | Pre Book Price:$2494

Nanomedicine Asia-Pacific Market Research Report, 2014 - 2020

Nanomedicine is the applied branch of nanotechnology. Application of nanomedicines ranges from nonmaterial to nanoelectronic and in the near future, it could possibly expand to molecular nanotechnology. Biological, pharmaceutical and ...

April 2018| $2850 | Pre Book Price:$2494

Autoimmune Disorders Treatment Asia-Pacific Market Research Report, 2014 - 2020

Graves disease, Multiple sclerosis, Myasthenia gravis, Rheumatoid arthritis, Pernicious anemia and Systemic lupus erythematosus are the most prevalent types of autoimmune disorders. The prevalence of autoimmune diseases is high in ...

April 2018| $2850 | Pre Book Price:$2494

2018 © Copyright Big Market Research

View Pricing >>